» Articles » PMID: 27484835

Tumor Microenvironment-responsive Micelles for Pinpointed Intracellular Release of Doxorubicin and Enhanced Anti-cancer Efficiency

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2016 Aug 4
PMID 27484835
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Internal stimuli, such as intracellular lysosomal pH, enzyme, redox and reduction, can be applied to improve biological specificity of chemotherapeutic drugs for cancer therapy. Thus, functionalized copolymers based on their response to specific microenvironment of tumor regions have been designed as smart drug vesicles for enhanced anti-cancer efficiency and reduced side effects. Herein, we reported dually pH/reduction-responsive novel micelles based on self-assembly of carboxymethyl chitosan-cysteamine-N-acetyl histidine (CMCH-SS-NA) and doxorubicin (DOX). The tailor-made dually responsive micelles demonstrated favorable stability in normal physiological environment and triggered rapid drug release in acidic and/or reduction environment. Additionally, the nanocarriers responded to the intracellular environment in an ultra-fast manner within several minutes, which led to the pinpointed release of DOX in tumor cells effectively and ensured higher DOX concentrations within tumor areas with the aid of targeted delivery, thereby leading to enhanced tumor ablation. Thus, this approach with sharp drug release behavior represented a versatile strategy to provide a promising paradigm for cancer therapy.

Citing Articles

Drug Delivery Based on Stimuli-Responsive Injectable Hydrogels for Breast Cancer Therapy: A Review.

Xin H, Naficy S Gels. 2022; 8(1).

PMID: 35049580 PMC: 8774468. DOI: 10.3390/gels8010045.


A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.

Hong W, Guo F, Yu N, Ying S, Lou B, Wu J Drug Des Devel Ther. 2021; 15:2843-2855.

PMID: 34234415 PMC: 8255901. DOI: 10.2147/DDDT.S320119.


Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues.

Huang H, Chen L, Sun W, Du H, Dong S, Ahmed A Theranostics. 2021; 11(2):906-924.

PMID: 33391512 PMC: 7738847. DOI: 10.7150/thno.47446.


Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy.

Guo F, Fu Q, Zhou K, Jin C, Wu W, Ji X J Nanobiotechnology. 2020; 18(1):48.

PMID: 32183823 PMC: 7076984. DOI: 10.1186/s12951-020-00595-5.


Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors.

Zhang X, Shen L, Liu Q, Hou L, Huang L J Control Release. 2019; 309:173-180.

PMID: 31362079 PMC: 6815713. DOI: 10.1016/j.jconrel.2019.07.039.